--A French subsidiary of pharmaceutical company Merck KGaA is facing further investigations in France for potentially misleading information related to a change in formula of its thyroid medication Levothyrox, news agency AFP reports.

--The unit said investigations aren't related to the quality of the new formula but communications related to the change in 2017, AFP reports.

--Shares in Merck KGaA are down 4% at EUR164.70.

Write to Kim Richters at kim.richters@wsj.com

(END) Dow Jones Newswires

October 19, 2022 05:17 ET (09:17 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Merck KGaA (PK) 차트를 더 보려면 여기를 클릭.
Merck KGaA (PK) (USOTC:MKKGY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Merck KGaA (PK) 차트를 더 보려면 여기를 클릭.